Ocugen (OCGN) Operating Expenses (2014 - 2026)
Ocugen's (OCGN) quarterly Operating Expenses came in at $19.4 million in Q1 2026, up 21.21% YoY from $16.0 million in Q1 2025, and up 15.3% on a QoQ basis from $16.8 million in Q4 2025.
Ocugen (OCGN) Operating Expenses (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Operating Expenses data on file, last reported at $19.4 million in Q1 2026.
- Quarterly Operating Expenses rose 21.21% year-over-year to $19.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.7 million (up 14.87% YoY) and the FY2025 annual result came in at $67.3 million, up 14.48% from the prior year.
- Operating Expenses advanced to $19.4 million in Q1 2026, from $16.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $25.6 million in Q3 2022 to a low of $12.9 million in Q4 2023.
- A 5-year average of $18.2 million and a median of $16.8 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 176.75% — and 2023, when it slumped 46.63%.
- Tracing OCGN's Operating Expenses over 5 years: stood at $24.2 million in 2022, then tumbled by 46.63% to $12.9 million in 2023, then climbed by 12.91% to $14.6 million in 2024, then advanced by 15.05% to $16.8 million in 2025, then advanced by 15.3% to $19.4 million in 2026.
- The last three Operating Expenses figures came in at $19.4 million (Q1 2026), $16.8 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | 17.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.93 Mn |
| Mar 31, 2026 | 19.37 Mn |
| Dec 31, 2025 | 16.80 Mn |
| Sep 30, 2025 | 19.38 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 15.98 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | 14.39 Mn |
| Jun 30, 2024 | 16.59 Mn |
| Mar 31, 2024 | 13.23 Mn |
| Dec 31, 2023 | 12.93 Mn |
| Sep 30, 2023 | 16.13 Mn |
| Jun 30, 2023 | 24.03 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.23 Mn |
| Sep 30, 2022 | 25.58 Mn |
| Jun 30, 2022 | 22.22 Mn |
| Mar 31, 2022 | 19.53 Mn |
| Dec 31, 2021 | 14.57 Mn |
| Sep 30, 2021 | 10.79 Mn |